Which patients with non‐ischaemic cardiomyopathy should receive a defibrillator?
- Resource Type
- Article
- Authors
- Straw, Sam; Flett, Andrew; Witte, Klaus K.
- Source
- European Journal of Heart Failure. Jun2024, Vol. 26 Issue 6, p1432-1434. 3p.
- Subject
- *IMPLANTABLE cardioverter-defibrillators
*VENTRICULAR ejection fraction
*HEART failure
*CARDIOMYOPATHIES
*DEFIBRILLATORS
*CARDIAC arrest
- Language
- ISSN
- 1388-9842
The article discusses the use of implantable cardioverter-defibrillators (ICDs) in patients with non-ischaemic cardiomyopathy. It highlights the results of the DANISH trial, which showed that while ICDs reduced the risk of sudden death, they did not improve overall survival. The article also explores the limitations of using the New York Heart Association (NYHA) classification to determine ICD candidacy and suggests that myocardial scar detected through cardiac magnetic resonance (CMR) could be a better risk stratification tool. Ongoing clinical trials aim to provide more evidence on the effectiveness of ICDs in this population. In the meantime, physicians should consider enrolling eligible patients in clinical trials to further advance knowledge in this area. [Extracted from the article]